Representatives of Greek pharmaceutical manufacturers and importershave warned the government that its proposal to introduce new pricing for pharmaceutical products, beginning on August 1, following the comprehensive product "recosting" exercise which has been carried out this month (Marketletter July 7), will lead to "great confusion" and product shortages.
Given that these developments are taking place during the vacation period, the manufacturers have stated that they are unable to cope with these changes.
To alleviate the problem, the industry representatives suggested to the government that pharmacists be allowed to choose whether to sell their current product stocks at their existing prices or at the new levels, which have been arrived at using different cost elements and taxes.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze